|08/27/15||Xtant Medical to Present at the Rodman Renshaw 17th Annual Global Investment Conference|
|BELGRADE, Mont., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today announced that its Chief Executive Officer, Dan Goldberger, Chief Financial Officer, John Gandolfo and Executive Vice President and Chief Scientific Officer Dr. David Kirschman will present at the Rodman Renshaw 17th Annual Global Investment Conference, t... |
|08/25/15||Xtant Medical Announces FDA Approval of OsteoSelect(R) PLUS|
|BELGRADE, Mont., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin International, Inc., has received FDA 510(k) clearance of OsteoSelect PLUS Demineralized Bone Matrix (DBM) Putty.
OsteoSelect PLUS is a next-generation DBM putty, comprised of OsteoSelect Putty with the addition of demineralized cortical chips. Aligned with th... |
|08/12/15||Xtant Medical Reports First Half 2015 Financial Results|
|First Half Xtant(TM) Medical Pro Forma Combined 2015 Highlights:
On July 31, 2015, the Company announced the close of its acquisition of X-spine Systems, Inc.
Pro forma combined revenue increased 12.6% to $43.4 million from $38.5 million in the first half of 2014
Pro forma gross profit increased 14.3% to $28.0 million compared to $24.5 million in the first half of 2014
Pro forma gross margins improved to 64.6%, an increase from 63.6% in the first half of 2014
Pro ... |
|08/04/15||Xtant Medical Holdings, Inc. to Report Second Quarter 2015 Financial Results on August 12, 2015|
|BELGRADE, Mont., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended June 30, 2015, at the close of the financial markets on August 12, 2015. An accompanying conference call will be hosted by Dan Goldberger, Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss the results. The call will be held at 10:00 AM E... |